[ad_1]
German well being information startup Temedica raised one other €25 million in Collection B funding led by current investor MIG Capital and an undisclosed Munich-based household workplace.
The most recent inflow of capital brings its whole Collection B elevate to €42 million. The corporate had beforehand introduced it had scooped up €17 million in January 2020.
WHAT THEY DO
The Munich-based firm presents the Permea real-world information platform and builds digital companion apps, which permit sufferers to trace signs and drugs use.
Temedica’s ecosystem combines insurance coverage information, gross sales information from medical merchandise, affected person expertise info and patient-reported information from their companion apps. The corporate pitches the information platform as a technique to achieve perception into illness development, therapy effectiveness and drugs adherence for healthcare suppliers, researchers, and pharma and biotech corporations.
“Temedica’s imaginative and prescient is to make a pioneering contribution to the event of customized medication by linking health-relevant information to new, evidence-based insights. We’re satisfied that huge information units and utterly new forms of information play a key function on this, comparable to patient-generated information from giant populations outdoors of traditional scientific trials,” Gloria Seibert, Temedica founder and CEO, stated in a press release.
“These allow a totally new data and understanding of illnesses and their precise programs. I’m more than happy that our traders share this imaginative and prescient and accompany and help us as we proceed to increase the Temedica ecosystem.”
MARKET SNAPSHOT
Based in 2016, Temedica has beforehand created apps like Waya, geared towards weight reduction, and Pelvina, which aimed to assist ladies practice their pelvic flooring.
Final yr, the corporate partnered with Roche to launch Brisa, a digital administration app for a number of sclerosis sufferers. It is also working with Bristol Myers Squibb to develop an app for sufferers with psoriasis.
In January, Temedica launched its Permea information platform. The corporate later introduced it had entered into a knowledge collaboration with NOVENTI Well being SE, a German supplier of enterprise useful resource planning (ERP) techniques and claims administration instruments for pharmacies.
A variety of corporations goal to make use of real-world information, together with patient-collected information from wearables and apps, to generate well being insights or proof to help therapies. San Mateo, Calif.-based Evidation Well being raised $153 million in Collection E funding in 2021, whereas Aetion most lately scooped up $110 million in a Collection C spherical.
Source link